Antipodes Global
24344
Antipodes Global 24344 Strategy
'%3e%3cpath%20style='fill:none;stroke:%235e5e5e'%20d='M%2060,60%20H%2012%20V%2012%20H%2060%20Z%20M%2047.347,19.007%20c%20-6.228,6.057%20-16.326,6.057%20-22.555,0%20m%207.416,11.589%20h%204.325%20v%2017.302%20m%204.325,-0.769%20c%203.413,-3.319%208.947,-3.319%2012.36,0%20m%20-21.01,0%20c%20-3.413,-3.319%20-8.946,-3.319%20-12.359,0'/%3e%3c/g%3e%3c/svg%3e)
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
Funds News & Analysis
funds
Listed Investment Companies monthly performance: May 2025
The Morningstar LIC monthly report provides a snapshot of ASX-listed LICs, and whether they are trading at a premium or a discount to their net tangible assets (NTA).
funds
10 US stocks the best fund managers have been selling in 2025
Top investors have taken profits in these names.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,806.80 | 68.50 | -0.77% |
| CAC 40 | 7,766.21 | 41.96 | -0.54% |
| DAX 40 | 24,060.29 | 100.35 | -0.42% |
| Dow JONES (US) | 44,023.29 | 436.36 | -0.98% |
| FTSE 100 | 8,938.32 | 59.74 | -0.66% |
| HKSE | 24,684.28 | 94.16 | 0.38% |
| NASDAQ | 20,677.80 | 37.47 | 0.18% |
| Nikkei 225 | 39,642.40 | 35.62 | -0.09% |
| NZX 50 Index | 12,771.53 | 81.90 | 0.65% |
| S&P 500 | 6,243.76 | 24.80 | -0.40% |
| S&P/ASX 200 | 8,555.50 | 74.80 | -0.87% |
| SSE Composite Index | 3,499.70 | 5.30 | -0.15% |